Ajinomoto Bio-Pharma Services, a global provider of bio-pharmaceutical contract development and manufacturing services, has appointed Tony O’Neill as vice president of Compliance, U.S. Operations.
 
O’Neill brings extensive experience leading Quality, Manufacturing, and Operational Excellence Teams in the pharmaceutical and bio-pharmaceutical industry.
 
He joins Aji Bio-Pharma after 25 years at Allergan, where he held a number of Quality and Operational leadership positions in biologics manufacturing and development with responsibility both in Ireland and U.S. operations. His most recent roles include executive director quality operations and executive director risk management and compliance, where he was responsible for leading a team in developing standard policies and processes for data management and controls across a network of 14 sites.
 
“We are excited to welcome Tony O’Neill to our leadership team at Aji Bio-Pharma,” said Nobu Shimba, president and CEO of Aji Bio-Pharma, U.S. “With his extensive management experience, we are confident that Tony will be a strong leader for our teams as we provide our clients’ unique drug programs with dedicated attention, strong regulatory support, and focused quality. As we continue to expand our capacity and service offerings, including the addition of our new multi-purpose fill/finish suite, Tony’s expertise will be integral in ensuring the required sterility and regulatory standards are met for both cGMP clinical and commercial manufacturing.”